Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wolfram H Gerlich

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
The Lancet. Infectious Diseases|August 18, 2020
Good news from WHO on prevention of peripartum hepatitis B transmissionWolfram H Gerlich
Methods in Molecular Medicine|February 6, 2004
Study of the endocytosis and intracellular localization of subviral particles of hepatitis B virus in primary hepatocytesDieter Glebe, Wolfram H Gerlich
Clinical Laboratory|July 4, 2007
The serologic markers of hepatitis B virus infection--proper selection and standardized interpretationGregor Caspari, Wolfram H Gerlich
Virus Genes|November 5, 2020
Enigmatic PreS deletions in hepatitis B virus DNAWolfram H Gerlich, Dieter Glebe
Ebiomedicine|August 4, 2016
Development of an Allergy Immunotherapy Leads to a New Type of Hepatitis B VaccineWolfram H Gerlich, Dieter Glebe
BMJ (Clinical Research Ed.)|September 25, 2002
Reducing blood transfusion. Most important transfusion risks go unnoticed by public and politicsGregor Caspari, Wolfram H Gerlich, Lutz Gürtler
Methods in Molecular Medicine|February 6, 2004
Quantitative assay of hepatitis B surface antigen in serum or plasma using laurell electrophoresisWolfram H Gerlich, Ulrike Wend, Dieter Glebe
The New England Journal of Medicine|July 31, 2014
More on hepatitis B virus rtI233V mutation and resistance to adefovirAndreas Geipel, Dieter Glebe, Wolfram H Gerlich
Scandinavian Journal of Gastroenterology|February 18, 2006
Replacement of tenofovir with adefovir may result in reactivation of hepatitis B virus replicationOliver Schildgen, Heinz Hartmann, Wolfram H Gerlich
The New England Journal of Medicine|April 25, 2014
Hepatitis B virus rtI233V mutation and resistance to adefovirAndreas Geipel, Dieter Glebe, Hans Will, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
The Lancet. Infectious Diseases|August 18, 2020
Good news from WHO on prevention of peripartum hepatitis B transmissionWolfram H Gerlich
Methods in Molecular Medicine|February 6, 2004
Study of the endocytosis and intracellular localization of subviral particles of hepatitis B virus in primary hepatocytesDieter Glebe, Wolfram H Gerlich
Clinical Laboratory|July 4, 2007
The serologic markers of hepatitis B virus infection--proper selection and standardized interpretationGregor Caspari, Wolfram H Gerlich
Virus Genes|November 5, 2020
Enigmatic PreS deletions in hepatitis B virus DNAWolfram H Gerlich, Dieter Glebe
Ebiomedicine|August 4, 2016
Development of an Allergy Immunotherapy Leads to a New Type of Hepatitis B VaccineWolfram H Gerlich, Dieter Glebe
BMJ (Clinical Research Ed.)|September 25, 2002
Reducing blood transfusion. Most important transfusion risks go unnoticed by public and politicsGregor Caspari, Wolfram H Gerlich, Lutz Gürtler
Methods in Molecular Medicine|February 6, 2004
Quantitative assay of hepatitis B surface antigen in serum or plasma using laurell electrophoresisWolfram H Gerlich, Ulrike Wend, Dieter Glebe
The New England Journal of Medicine|July 31, 2014
More on hepatitis B virus rtI233V mutation and resistance to adefovirAndreas Geipel, Dieter Glebe, Wolfram H Gerlich
Scandinavian Journal of Gastroenterology|February 18, 2006
Replacement of tenofovir with adefovir may result in reactivation of hepatitis B virus replicationOliver Schildgen, Heinz Hartmann, Wolfram H Gerlich
The New England Journal of Medicine|April 25, 2014
Hepatitis B virus rtI233V mutation and resistance to adefovirAndreas Geipel, Dieter Glebe, Hans Will, et al.
Pageof 7